What is TheraPro?
TheraPro specializes in the development and distribution of advanced aluminum tools for Instrument Assisted Soft Tissue Mobilization (IASTM). These tools are engineered to enhance blood flow, reduce scar tissue, and alleviate muscle discomfort. Featuring a distinctive bump pattern for superior grip and a lightweight design for prolonged professional use, TheraPro's offerings are versatile. The tools are equipped with three professionally designed edges, catering to a wide spectrum of treatment techniques suitable for both seasoned practitioners and novices in myofascial release, trigger point therapy, and deep tissue work.
How much funding has TheraPro raised?
TheraPro has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in TheraPro
PPP
Public-Private Partnership
What's next for TheraPro?
The substantial capital infusion, particularly the recent strategic investment, positions TheraPro for significant growth and market penetration. This backing is likely to fuel advancements in product development, expand manufacturing capabilities, and bolster marketing efforts to reach a broader client base seeking effective and accessible myofascial release solutions. The company's focus on affordability and versatility in its IASTM tools suggests a strategy aimed at democratizing advanced physical therapy techniques.
See full TheraPro company page
